BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 18059324)

  • 21. Pharmacological therapy of acute ischaemic stroke: Achievements and problems.
    Moretti A; Ferrari F; Villa RF
    Pharmacol Ther; 2015 Sep; 153():79-89. PubMed ID: 26079382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotection in cerebral ischemia: emphasis on the SAINT trial.
    Chacon MR; Jensen MB; Sattin JA; Zivin JA
    Curr Cardiol Rep; 2008 Feb; 10(1):37-42. PubMed ID: 18416999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: from review to preview.
    Grupke S; Hall J; Dobbs M; Bix GJ; Fraser JF
    Clin Neurol Neurosurg; 2015 Feb; 129():1-9. PubMed ID: 25497127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombolytics in acute ischaemic stroke: historical perspective and future opportunities.
    Röther J; Ford GA; Thijs VN
    Cerebrovasc Dis; 2013; 35(4):313-9. PubMed ID: 23615379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinolytic treatment for acute ischaemic stroke.
    Mazumdar A; Derdeyn CP
    Expert Opin Pharmacother; 2006 Feb; 7(3):287-96. PubMed ID: 16448323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limiting neurological damage after stroke: a review of pharmacological treatment options.
    Read SJ; Hirano T; Davis SM; Donnan GA
    Drugs Aging; 1999 Jan; 14(1):11-39. PubMed ID: 10069406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombolytic agents for acute ischaemic stroke treatment: the past, present and future.
    Balami JS; Chen R; Sutherland BA; Buchan AM
    CNS Neurol Disord Drug Targets; 2013 Mar; 12(2):145-54. PubMed ID: 23394531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges in acute ischemic stroke clinical trials.
    Furlan AJ
    Curr Cardiol Rep; 2012 Dec; 14(6):761-6. PubMed ID: 22922833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental neuroprotection in ischemic stroke: a concise review.
    Rajah GB; Ding Y
    Neurosurg Focus; 2017 Apr; 42(4):E2. PubMed ID: 28366067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
    Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
    Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy for early reperfusion after stroke.
    Juttler E; Kohrmann M; Schellinger PD
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):656-63. PubMed ID: 17122798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in ischemic stroke treatment: neuroprotective and combination therapies.
    Lapchak PA; Araujo DM
    Expert Opin Emerg Drugs; 2007 Mar; 12(1):97-112. PubMed ID: 17355216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of uric acid as a potential neuroprotectant in acute ischemic stroke: a review of literature.
    Li R; Huang C; Chen J; Guo Y; Tan S
    Neurol Sci; 2015 Jul; 36(7):1097-103. PubMed ID: 25772077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
    Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
    Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies.
    Molina CA; Saver JL
    Stroke; 2005 Oct; 36(10):2311-20. PubMed ID: 16179577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute treatment for ischemic stroke in 2004.
    Mohammad YM; Divani AA; Kirmani JF; Harris-Lane P; Qureshi AI
    Emerg Radiol; 2004 Dec; 11(2):83-6. PubMed ID: 15309661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental treatments for acute ischaemic stroke.
    Sacco RL; Chong JY; Prabhakaran S; Elkind MS
    Lancet; 2007 Jan; 369(9558):331-41. PubMed ID: 17258673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotection as initial therapy in acute stroke. Third Report of an Ad Hoc Consensus Group Meeting. The European Ad Hoc Consensus Group.
    Cerebrovasc Dis; 1998; 8(1):59-72. PubMed ID: 9645985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reperfusion in acute ischaemic stroke: present and future].
    Herrera M; Gállego J; Muñoz R; Aymerich N; Zandio B
    An Sist Sanit Navar; 2008; 31 Suppl 1():31-46. PubMed ID: 18528442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy with neuroprotectants and thrombolytics in acute ischaemic stroke.
    Steiner T; Hacke W
    Eur Neurol; 1998 Jul; 40(1):1-8. PubMed ID: 9693224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.